{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:45:11Z","timestamp":1791287111349,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bbrc.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T23:20:59Z","timestamp":1515194459000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid"],"prefix":"10.1016","volume":"496","author":[{"given":"Naveen K.V.","family":"Gundala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vegi G.M.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-9508","authenticated-orcid":false,"given":"Undurti N.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.01.007_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/193229680900300101","article-title":"The increasing incidence of diabetes in the 21st century","volume":"3","author":"Klonoff","year":"2009","journal-title":"J.\u00a0Diabetes Sci. Technol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib2","series-title":"Global Report on Diabetes","isbn-type":"print","author":"WHO","year":"2016","ISBN":"https:\/\/id.crossref.org\/isbn\/9789241565257"},{"key":"10.1016\/j.bbrc.2018.01.007_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fendo.2017.00182","article-title":"Is there a role for bioactive lipids in the pathobiology of diabetes mellitus","volume":"8","author":"Das","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.bbrc.2018.01.007_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3181\/00379727-211-43950D","article-title":"Cytokines and nitric oxide in islet inflammation and diabetes","volume":"211","author":"McDaniel","year":"1996","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.bbrc.2018.01.007_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2018.01.007_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.bbrc.2018.01.007_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(95)00649-T","article-title":"Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus","volume":"368","author":"Gopaul","year":"1995","journal-title":"FEBS Lett."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2018.01.007_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1071\/RD01032","article-title":"Oxidative stress and altered prostanoid production in the placenta of streptozotocin-induced diabetic rats","volume":"14","author":"White","year":"2002","journal-title":"Reprod. Fertil. Dev."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2018.01.007_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-015-2374-6","article-title":"Rosmarinic acid modulates the antioxidant status and protects pancreatic tissues from glucolipotoxicity mediated oxidative stress in high-fat diet: streptozotocin-induced diabetic rats","volume":"404","author":"Govindaraj","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2018.01.007_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-008-9996-x","article-title":"Subclinical inflammation\/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and Type 2 diabetes patients","volume":"324","author":"Gokulakrishnan","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.bbrc.2018.01.007_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/nm.3705","article-title":"Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress","volume":"20","author":"Hasnain","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2018.01.007_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbrc.2007.08.090","article-title":"Effect of selective cyclooxygenase-2 (COX-2) inhibitor treatment on glucose-stimulated insulin secretion in C57BL\/6 mice","volume":"363","author":"Fujita","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.01.007_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2009.10.065","article-title":"Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia\/reperfusion rats","volume":"1309","author":"Tsuruta","year":"2010","journal-title":"Brain Res."},{"issue":"5\u20136","key":"10.1016\/j.bbrc.2018.01.007_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/ars.2005.7.526","article-title":"Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases","volume":"7","author":"Wu","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbrc.2018.01.007_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/clp.13.32","article-title":"Lipoxins, resolvins, protectins, maresins and nitrolipids and their clinical implications with specific reference to diabetes mellitus and other diseases: part II","volume":"8","author":"Das","year":"2013","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib17","series-title":"Metabolic Syndrome Pathophysiology: the Role of Essential Fatty Acids and Their Metabolites","author":"Das","year":"2010"},{"key":"10.1016\/j.bbrc.2018.01.007_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/153537020222701106","article-title":"Is metabolic syndrome X an inflammatory condition?","volume":"227","author":"Das","year":"2002","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"4","key":"10.1016\/j.bbrc.2018.01.007_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","article-title":"Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition","volume":"6","author":"Hameed","year":"2015","journal-title":"World J. Diabetes"},{"issue":"2","key":"10.1016\/j.bbrc.2018.01.007_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2018.01.007_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0899-9007(00)00468-8","article-title":"Prevention of chemically-induced diabetes mellitus in experimental animals by polyunsaturated fatty acids","volume":"17","author":"Krishna Mohan","year":"2001","journal-title":"Nutrition"},{"key":"10.1016\/j.bbrc.2018.01.007_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1054\/plef.2000.0236","article-title":"Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus","volume":"64","author":"Suresh","year":"2001","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbrc.2018.01.007_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0899-9007(02)00856-0","article-title":"Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of \u03c9-6 fatty acids","volume":"19","author":"Suresh","year":"2003","journal-title":"Nutrition"},{"key":"10.1016\/j.bbrc.2018.01.007_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0899-9007(02)00855-9","article-title":"Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of \u03c9-3 fatty acids","volume":"19","author":"Suresh","year":"2003","journal-title":"Nutrition"},{"key":"10.1016\/j.bbrc.2018.01.007_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.plefa.2005.11.006","article-title":"Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus","volume":"74","author":"Suresh","year":"2006","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbrc.2018.01.007_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/biof.1336","article-title":"Arachidonic acid (AA) and lipoxin A4 (LXA4) attenuate alloxan-induced cytotoxicity to RIN5F cells in\u00a0vitro and type 1 diabetes mellitus in\u00a0vivo","volume":"43","author":"Naveen","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.bbrc.2018.01.007_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2004.04.006","article-title":"Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in\u00a0vitro","volume":"71","author":"Sailaja Devi","year":"2004","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbrc.2018.01.007_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.plefa.2005.09.003","article-title":"Effect of prostaglandins against alloxan-induced diabetes mellitus","volume":"74","author":"Sailaja","year":"2006","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbrc.2018.01.007_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nut.2016.10.004","article-title":"Arachidonic acid (AA) and lipoxin A4 (LXA4) attenuate streptozotocin-induced cytotoxicity to RIN5F cells in\u00a0vitro and type 1 and type 2 diabetes mellitus in\u00a0vivo","volume":"35","author":"Naveen","year":"2017","journal-title":"Nutrition"},{"key":"10.1016\/j.bbrc.2018.01.007_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000088261","article-title":"Metabolic and vascular effects of tumor necrosis factor-\u03b1 blockade with etanercept in obese patients with type 2 diabetes","volume":"42","author":"Dominguez","year":"2005","journal-title":"J.\u00a0Vasc. Res."},{"key":"10.1016\/j.bbrc.2018.01.007_bib31","first-page":"83","article-title":"Anti-tumor necrosis factor-\u03b1 blockade improves insulin resistance in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib32","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1210\/jc.2010-1170","article-title":"TNF-\u03b1 antagonism with Etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome","volume":"96","author":"Stanley","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib33","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.01.007_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/db08-0536","article-title":"Macrophage content in subcutaneous adipose tissue: associations with adiposity, inflammatory markers, and whole-body insulin action in healthy Pima Indians","volume":"58","author":"Ortega Martinez de Victoria","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2018.01.007_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fendo.2013.00097","article-title":"Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health","volume":"4","author":"Choi","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.bbrc.2018.01.007_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yexcr.2017.02.018","article-title":"Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss","volume":"352","author":"Liu","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.bbrc.2018.01.007_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108525","article-title":"Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.01.007_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2012.11.009","article-title":"Arachidonic acid and lipoxin A4 as possible anti-diabetic molecules","volume":"88","author":"Das","year":"2013","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"issue":"5","key":"10.1016\/j.bbrc.2018.01.007_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20100282","article-title":"Arachidonic acid actions on functional integrity and attenuation of the negative effects of palmitic acid in a clonal pancreatic \u03b2-cell line","volume":"120","author":"Keane","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.bbrc.2018.01.007_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1042\/bj0510018","article-title":"The effect of salicylate on glycosuria, blood glucose and liver glycogen of the alloxan-diabetic rat","volume":"51","author":"Smith","year":"1952","journal-title":"Biochem. J."},{"issue":"5053","key":"10.1016\/j.bbrc.2018.01.007_bib41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.2.5053.1071","article-title":"Aspirin and diabetes mellitus","volume":"2","author":"Reid","year":"1957","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.bbrc.2018.01.007_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-61-1-160","article-title":"Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus","volume":"61","author":"Giugliano","year":"1985","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib43","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Novel lipid mediators promote resolution of acute inflammation. Impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2018.01.007_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2015.08.049","article-title":"COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance","volume":"785","author":"Poorani","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.01.007_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0952-3278(95)90066-7","article-title":"Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease","volume":"52","author":"Das","year":"1995","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbrc.2018.01.007_bib46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.metabol.2015.04.005","article-title":"Low blood and vitreal BDNF, LXA4 and altered Th1\/Th2 cytokine balance as potential risk factors for diabetic retinopathy","volume":"64","author":"Kaviarasan","year":"2015","journal-title":"Metabolism"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1830007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1830007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:58:31Z","timestamp":1760007511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1830007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0006291X1830007X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.007","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}